Asalyxa Bio

📍 Southfield, United States🗓 Founded 2020👥 4 employees💰 Last funded Apr 2021
Biotechnology Research🌐 asalyxabio.com
Website LinkedIn
Asalyxa is focused on the rapid development of a revolutionary neutrophil-targeting drug platform. The versatility of Asalyxa’s proprietary platform allows for the direct delivery of microparticles into neutrophils, making the platform ideal for a variety of diseases where treatments are limited or do not exist. Asalyxa is committed to developing neutrophil targeting treatments for diseases with a high unmet medical need, allowing today’s patients to enjoy a healthier tomorrow.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Asalyxa Bio?
Asalyxa Bio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Asalyxa Bio last raise funding?
The most recent investment in Asalyxa Bio recorded on gritt.io was in April 2021.
When was Asalyxa Bio founded?
Asalyxa Bio was founded in 2020.
What industry is Asalyxa Bio in?
Asalyxa Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Asalyxa Bio based?
Asalyxa Bio is headquartered in Southfield, United States.